The global chronic lymphocytic leukemia treatment market accounted for US$ 8.2 Bn in 2018 and burgeoning over the forthcoming years. Lifestyle factors and rising investment for cancer research, technological advancements in healthcare, increasing research & development activities, rising occurrence of leukemia as well as CLL are some key factors influencing the market growth. However, factors such as strict government rules and high cost of the treatments are hampering the market growth ... Read more